REVVITY, INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REVVITY, INC stock issued during period, value, stock options exercised for the quarter ending 2011-07-03 was -$5.52M.
- REVVITY, INC stock issued during period, value, stock options exercised for the quarter ending 2011-04-03 was -$18.03M.
- REVVITY, INC stock issued during period, value, stock options exercised for the quarter ending 2011-01-02 was -$13.86M.
- REVVITY, INC stock issued during period, value, stock options exercised for the quarter ending 2010-10-03 was -$2.12M.
- REVVITY, INC stock issued during period, value, stock options exercised for fiscal 2017 was $14.42M, a 3.27% decline from fiscal 2016.
- REVVITY, INC stock issued during period, value, stock options exercised for fiscal 2016 was $14.90M, a 39.05% decline from fiscal 2014.
- REVVITY, INC stock issued during period, value, stock options exercised for fiscal 2014 was $24.45M.
- REVVITY, INC stock issued during period, value, stock options exercised for fiscal 2013 was -$20.31M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2017-01-01 | $14.42M 10-K · filed 2017-02-28 | |
| 2016-01-03 | $14.90M 10-K · filed 2017-02-28 | |
| 2014-12-28 | $24.45M 10-K · filed 2017-02-28 | |
| 2013-12-29 | -$20.31M 10-K · filed 2016-03-01 | |
| 2012-12-30 | -$32.48M 10-K · filed 2015-02-24 | |
| 2012-01-01 | -$23.74M 10-K · filed 2014-02-25 | |
| 2011-07-03 | -$5.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-10 | -$39.54M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-04-03 | -$18.03M 10-Q · filed 2011-05-10 | -$34.63M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-01-02 | -$13.86M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$29.04M 10-K · filed 2013-02-26 |
| 2010-10-03 | -$2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | -$19.15M derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-07-04 | -$613.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-10 | -$17.21M derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-04-04 | -$12.43M 10-Q · filed 2011-05-10 | |
| 2010-01-03 | -$3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$6.24M 10-K · filed 2012-02-28 |
| 2009-10-04 | -$183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | |
| 2008-12-28 | -$43.74M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |